AOD-9604 | CAS#221231-10-3
US$ 27.26
glutathione parkinsons disease therapy perlmutter Frontiers Glutathione metabolism and Parkinson's disease
Description
A., Panji, M
SuYAWuJZhangLZhangQSuDMHePet al
A.GallegoM
It is noteworthy that the rate of phase variation is modulated in the meningococcal population due to the presence of mutator phenotypes (see below)
